瑞士监管机构授予Morderna二价新冠加强疫苗用于18岁及以上成人的临时授权

原文链接 https://cn.wsj.com/articles/%E7%91%9E%E5%A3%AB%E7%9B%91%E7%AE%A1%E6%9C%BA%E6%9E%84%E6%8E%88%E4%BA%88morderna%E4%BA%8C%E4%BB%B7%E6%96%B0%E5%86%A0%E5%8A%A0%E5%BC%BA%E7%96%AB%E8%8B%97%E7%94%A8%E4%BA%8E18%E5%B2%81%E5%8F%8A%E4%BB%A5%E4%B8%8A%E6%88%90%E4%BA%BA%E7%9A%84%E4%B8%B4%E6%97%B6%E6%8E%88%E6%9D%83-11661771105

Moderna Inc.周一表示,瑞士监管机构已授予其二价奥密克戎靶向新冠加强疫苗临时授权,用于18岁及以上的成年人。

原文链接 https://cn.wsj.com/articles/%E7%91%9E%E5%A3%AB%E7%9B%91%E7%AE%A1%E6%9C%BA%E6%9E%84%E6%8E%88%E4%BA%88morderna%E4%BA%8C%E4%BB%B7%E6%96%B0%E5%86%A0%E5%8A%A0%E5%BC%BA%E7%96%AB%E8%8B%97%E7%94%A8%E4%BA%8E18%E5%B2%81%E5%8F%8A%E4%BB%A5%E4%B8%8A%E6%88%90%E4%BA%BA%E7%9A%84%E4%B8%B4%E6%97%B6%E6%8E%88%E6%9D%83-11661771105